nach oben

The International Journal of Cardiovascular Imaging

Erschienen in:

03.09.2018 | Original Paper

Treatment of left accessory cardiac pathway conduction disorders using radiofrequency catheter ablation under the guidance of the Ensite NavX 3D mapping system: a retrospective study

verfasst von: Zhang Dengke, Li Lan, Shen Xiangli, Jiang Shubin

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

To investigate the effectiveness and safety of using the Ensite NavX three-dimensional (3D) mapping system during Radiofrequency catheter ablation (RFCA) of left accessory pathway (AP) disorders. A total of 227 patients having their left AP treated by RFCA, were classified into study group (n = 112) and the control group (n = 115). X-ray irradiation time and exposure doses during the course of the operations were recorded. Time taken to place the mapping catheter along with total duration of operations and procedural complications were compared. The X-ray irradiation time and exposure doses in the course of manipulating the ablation catheters were significantly lower in the study group compared to control (5.1 ± 2.3 min vs. 13.1 ± 3.1 min; P < 0.05 and 5.7 ± 2.6 mGy vs. 17.8 ± 4.3 mGy; P < 0.05, respectively). The total duration of operation was also significantly shorter in the study group compared to control (53.1 ± 18.8 min vs. 62.3 ± 20.6 min; P < 0.05). No procedural complications were reported in both groups. The irradiation time and exposure dose along with total operation duration was significantly reduced when the Ensite NavX mapping system was used during RFCA in comparison with traditional X-ray fluoroscopy method.

Ganz LI, Friedman PL (1995) Supraventricular tachycardia. N Engl J Med 332:162–173. https://doi.org/10.1056/NEJM199501193320307 CrossRefPubMed

Delacrétaz E (2006) Clinical practice. Supraventricular tachycardia. N Engl J Med 354:1039–1051. https://doi.org/10.1056/NEJMcp051145 CrossRefPubMed

DiMarco JP, Miles W, Akhtar M et al (1990) Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group. Ann Intern Med 113:104–110CrossRefPubMed

Holdgate A, Foo A (2006) Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD005154.pub2 CrossRefPubMed

Borggrefe M, Budde T, Podczeck A, Breithardt G (1987) High frequency alternating current ablation of an accessory pathway in humans. J Am Coll Cardiol 10:576–582CrossRefPubMed

Kay GN, Epstein AE, Dailey SM, Plumb VJ (1993) Role of radiofrequency ablation in the management of supraventricular arrhythmias: experience in 760 consecutive patients. J Cardiovasc Electrophysiol 4:371–389CrossRefPubMed

Roguin A, Goldstein J, Bar O (2012) Brain tumours among interventional cardiologists: a cause for alarm? Report of four new cases from two cities and a review of the literature. EuroIntervention 7:1081–1086. https://doi.org/10.4244/EIJV7I9A172 CrossRefPubMed

Heidbuchel H, Wittkampf FHM, Vano E et al (2014) Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedures. Europace 16:946–964. https://doi.org/10.1093/europace/eut409 CrossRefPubMed

Ko JK, Deal BJ, Strasburger JF, Benson DW (1992) Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 69:1028–1032CrossRefPubMed

10.

Porter MJ, Morton JB, Denman R et al (2004) Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 1:393–396. https://doi.org/10.1016/j.hrthm.2004.05.007 CrossRefPubMed

11.

Wellens HJ, Brugada P (1988) Mechanisms of supraventricular tachycardia. Am J Cardiol 62:10D–15DCrossRefPubMed

12.

Casella M, Pelargonio G, Dello Russo A et al (2011) “Near-zero” fluoroscopic exposure in supraventricular arrhythmia ablation using the EnSite NavX™ mapping system: personal experience and review of the literature. J Interv Card Electrophysiol 31:109–118. https://doi.org/10.1007/s10840-011-9553-5 CrossRefPubMed

13.

Cheng CH, Sanders GD, Hlatky MA et al (2000) Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. Ann Intern Med 133:864–876CrossRefPubMed

14.

Goldberg AS, Bathina MN, Mickelsen S et al (2002) Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy). Am J Cardiol 89:1120–1123CrossRefPubMed

15.

Huo Y, Christoph M, Forkmann M et al (2015) Reduction of radiation exposure during atrial fibrillation ablation using a novel fluoroscopy image integrated 3-dimensional electroanatomic mapping system: a prospective, randomized, single-blind, and controlled study. Heart Rhythm 12:1945–1955. https://doi.org/10.1016/j.hrthm.2015.05.018 CrossRefPubMed

16.

Papagiannis J, Avramidis D, Alexopoulos C, Kirvassilis G (2011) Radiofrequency ablation of accessory pathways in children and congenital heart disease patients: impact of a nonfluoroscopic navigation system. Pacing Clin Electrophysiol 34:1288–1396. https://doi.org/10.1111/j.1540-8159.2011.03170.x CrossRefPubMed

17.

Casella M, Dello Russo A, Pelargonio G et al (2016) Near zero fluoroscopic exposure during catheter ablation of supraventricular arrhythmias: the no-party multicentre randomized trial. Europace 18:1565–1572. https://doi.org/10.1093/europace/euv344 CrossRefPubMed

18.

Giaccardi M, Del Rosso A, Guarnaccia V et al (2016) Near-zero X-ray in arrhythmia ablation using a 3-dimensional electroanatomic mapping system: a multicenter experience. Heart Rhythm 13:150–156. https://doi.org/10.1016/j.hrthm.2015.09.003 CrossRefPubMed

19.

Jin-rui G, Lihui Z, Yan Y et al (2016) Total three-dimensional electrophysiology mode:a single-center experience of 5093 patients. Chin J Cardiac Arrhythm 20:187–193

20.

Bingbo H, Yan Y, Kuijun Z et al (2014) Reducing radiation dose during catheter ablation of paroxysmal supraventricular tachycardia. Chin J Cardiac Arrhythm 18:353–356

21.

Patel SM, McLeod CJ, Friedman PA et al (2011) Successful ablation of a left-sided accessory pathway in a patient with coronary sinus atresia and arteriovenous fistula: clinical and developmental insights. Indian Pacing Electrophysiol J 11:43–49PubMedPubMedCentral

22.

Cismaru G, Muresan L, Puiu M et al (2017) Ablation of a left-sided accessory pathway with near-zero fluoroscopy in a 9-year-old boy. Oxf Med Case Rep. https://doi.org/10.1093/omcr/omx052 CrossRef

23.

Tuzcu V (2012) Significant reduction of fluoroscopy in pediatric catheter ablation procedures: long-term experience from a single center. Pacing Clin Electrophysiol 35:1067–1073. https://doi.org/10.1111/j.1540-8159.2012.03472.x CrossRefPubMed

24.

Seizer P, Bucher V, Frische C et al (2016) Efficacy and safety of zero-fluoroscopy ablation for supraventricular tachycardias. Use of optional contact force measurement for zero-fluoroscopy ablation in a clinical routine setting. Herz 41:241–245. https://doi.org/10.1007/s00059-015-4358-4 CrossRefPubMed

25.

Ma Y, Qiu J, Yang Y, Tang A (2015) Catheter ablation of right-sided accessory pathways in adults using the three-dimensional mapping system: a randomized comparison to the conventional approach. PLoS ONE 10:e0128760. https://doi.org/10.1371/journal.pone.0128760 CrossRefPubMedPubMedCentral

26.

See J, Amora JL, Lee S et al (2016) Non-fluoroscopic navigation systems for radiofrequency catheter ablation for supraventricular tachycardia reduce ionising radiation exposure. Singapore Med J 57:390–395. https://doi.org/10.11622/smedj.2016017 CrossRefPubMedPubMedCentral

27.

Earley MJ, Showkathali R, Alzetani M et al (2006) Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial. Eur Heart J 27:1223–1229. https://doi.org/10.1093/eurheartj/ehi834 CrossRefPubMed

28.

Romero J, Lupercio F, Goodman-Meza D et al (2016) Electroanatomic mapping systems (CARTO/EnSite NavX) vs. conventional mapping for ablation procedures in a training program. J Interv Card Electrophysiol 45:71–80. https://doi.org/10.1007/s10840-015-0073-6 CrossRefPubMed

Titel: Treatment of left accessory cardiac pathway conduction disorders using radiofrequency catheter ablation under the guidance of the Ensite NavX 3D mapping system: a retrospective study
verfasst von: Zhang Dengke
Li Lan
Shen Xiangli
Jiang Shubin
Publikationsdatum: 03.09.2018
Verlag: Springer Netherlands
Erschienen in: The International Journal of Cardiovascular Imaging / Ausgabe 3/2019
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-018-1449-3

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Correlation of FFR-derived from CT and stress perfusion CMR with invasive FFR in intermediate-grade coronary artery stenosis

Proteinuria is an independent predictor of rapid progression of mild to moderate aortic stenosis in patients with preserved renal function

Impact of tissue protrusion after coronary stenting in patients with ST-segment elevation myocardial infarction

A propensity score matched valuation on feasibility of low frame rate fluoroscopy during primary percutaneous coronary intervention for patients with STEMI

Congenital pseudoaneurysm of the mitral-aortic intervalvular fibrosa with a 5 years’ follow up